# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Feb 14, 2022

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2022-02-14
- Accepted by EDGAR: Feb 14, 2022, 09:00 ET
- Period: 2022-02-11
- Accession: 0001493152-22-004309
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000149315222004309/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000149315222004309/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000149315222004309/form8-k.htm

Filed Feb 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-004309. Last ingested by Listed: Nov 13, 2026, 16:09 ET. No prices; not investment advice.
